Cargando…

Alzheimer’s disease and its treatment costs: case study in the Czech Republic

This paper deals with the analysis of the costs, applied, for example, when treating specific diseases – an important aid in prioritizing the process of resource allocation. In our review, the specific disease is dementia caused by Alzheimer’s disease. This paper aims to provide more information on...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohelska, Hana, Maresova, Petra, Valis, Martin, Kuca, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574902/
https://www.ncbi.nlm.nih.gov/pubmed/26396519
http://dx.doi.org/10.2147/NDT.S87503
_version_ 1782390688630964224
author Mohelska, Hana
Maresova, Petra
Valis, Martin
Kuca, Kamil
author_facet Mohelska, Hana
Maresova, Petra
Valis, Martin
Kuca, Kamil
author_sort Mohelska, Hana
collection PubMed
description This paper deals with the analysis of the costs, applied, for example, when treating specific diseases – an important aid in prioritizing the process of resource allocation. In our review, the specific disease is dementia caused by Alzheimer’s disease. This paper aims to provide more information on the partial costs per patient that are calculated according to the aggregated data from publicly available sources as well as from the results of authors’ own investigation. The University Hospital in Hradec Králové and the General Health Insurance Company of the Czech Republic participated in this research. The elementary research objective was to compare the costs per patient diagnosed early onset, to those of the patient diagnosed later. The Czech Republic lacks information regarding dementia. Therefore, these issues require attention. The methods used in this paper included time series analyses, methods of direct questioning, interviews with experts, and analyses of medical documentation. These methods were combined to exploit their particular advantages and to ensure the issues discussed, were covered. The investigation showed that the underpinning of patients with Alzheimer’s disease at early onset is advantageous from an economic perspective, because the cost of outpatient care is much lower compared with that of inpatient care. The international comparisons of the volume of care provided should be approached with great caution. These are based solely on the facts of various expert estimates and are not usually supported by hard data. Yet, they still illustrate the overall view of our ability to take care of people with dementia. According to experts, care in the Czech Republic significantly lags behind the rest of developed Europe. While services are provided to 26% of people with dementia in Germany and 50% in France, the experts estimate that services are provided to only 10% of the population in the Czech Republic. If we were to offer a similar volume of services in the Czech Republic, to the same extent as the average in Europe, we would have to triple the existing capacities.
format Online
Article
Text
id pubmed-4574902
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45749022015-09-22 Alzheimer’s disease and its treatment costs: case study in the Czech Republic Mohelska, Hana Maresova, Petra Valis, Martin Kuca, Kamil Neuropsychiatr Dis Treat Review This paper deals with the analysis of the costs, applied, for example, when treating specific diseases – an important aid in prioritizing the process of resource allocation. In our review, the specific disease is dementia caused by Alzheimer’s disease. This paper aims to provide more information on the partial costs per patient that are calculated according to the aggregated data from publicly available sources as well as from the results of authors’ own investigation. The University Hospital in Hradec Králové and the General Health Insurance Company of the Czech Republic participated in this research. The elementary research objective was to compare the costs per patient diagnosed early onset, to those of the patient diagnosed later. The Czech Republic lacks information regarding dementia. Therefore, these issues require attention. The methods used in this paper included time series analyses, methods of direct questioning, interviews with experts, and analyses of medical documentation. These methods were combined to exploit their particular advantages and to ensure the issues discussed, were covered. The investigation showed that the underpinning of patients with Alzheimer’s disease at early onset is advantageous from an economic perspective, because the cost of outpatient care is much lower compared with that of inpatient care. The international comparisons of the volume of care provided should be approached with great caution. These are based solely on the facts of various expert estimates and are not usually supported by hard data. Yet, they still illustrate the overall view of our ability to take care of people with dementia. According to experts, care in the Czech Republic significantly lags behind the rest of developed Europe. While services are provided to 26% of people with dementia in Germany and 50% in France, the experts estimate that services are provided to only 10% of the population in the Czech Republic. If we were to offer a similar volume of services in the Czech Republic, to the same extent as the average in Europe, we would have to triple the existing capacities. Dove Medical Press 2015-09-11 /pmc/articles/PMC4574902/ /pubmed/26396519 http://dx.doi.org/10.2147/NDT.S87503 Text en © 2015 Mohelska et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Mohelska, Hana
Maresova, Petra
Valis, Martin
Kuca, Kamil
Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title_full Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title_fullStr Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title_full_unstemmed Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title_short Alzheimer’s disease and its treatment costs: case study in the Czech Republic
title_sort alzheimer’s disease and its treatment costs: case study in the czech republic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574902/
https://www.ncbi.nlm.nih.gov/pubmed/26396519
http://dx.doi.org/10.2147/NDT.S87503
work_keys_str_mv AT mohelskahana alzheimersdiseaseanditstreatmentcostscasestudyintheczechrepublic
AT maresovapetra alzheimersdiseaseanditstreatmentcostscasestudyintheczechrepublic
AT valismartin alzheimersdiseaseanditstreatmentcostscasestudyintheczechrepublic
AT kucakamil alzheimersdiseaseanditstreatmentcostscasestudyintheczechrepublic